Skip to main content
Top
Published in:

Open Access 24-02-2025 | Anti-NMDA Receptor Encephalitis | Case Report

Time moving 100-fold slower: time distortion as a diagnostic clue in anti-NMDA receptor encephalitis

Authors: Risa Hirata, Hisashi Wada, Kazunori Yamamoto, Yuji Sogi, Hiroto Muzuta, Yu Isaka, Michitaka Funayama

Published in: BMC Neurology | Issue 1/2025

Login to get access

Abstract

Background

The primary symptoms in the early stages of anti-NMDA receptor encephalitis are psychiatric manifestations, making it difficult to distinguish from psychiatric disorders. While anti-NMDA receptor encephalitis requires a completely different treatment approach, the specific psychiatric features of the condition remain poorly identified. Although previous studies have suggested that altered perceptions may be characteristic, few case reports focus on altered perceptions of time or time distortion, a phenomenon closely linked to NMDA receptor dysfunction as seen in individuals using NMDA receptor inhibitors like ketamine and phencyclidine. In this report, we describe two cases of anti-NMDA receptor encephalitis manifesting pronounced time distortion in its early stages, which may serve as diagnostic clues for the early diagnosis and treatment of this potentially lethal condition.

Case presentations

Two cases of Anti-NMDA receptor encephalitis, both marked by significant time distortion in the early stages and showing near-complete recovery with immunotherapy, are presented in detail. In both cases, time distortion was the predominant symptom among the psychiatric manifestations. Case 1: A middle-aged man experienced a pronounced perception of time moving 100 times slower in the early stages, accompanied by feelings of detachment and auditory abnormalities. This time distortion persisted for over a year, even after other symptoms had fully resolved. Case 2: A young woman reported that time seemed to move two to three times slower in the early stages. Although she did not initially mention time distortion, she confirmed it when specifically questioned.

Conclusions

Our report suggests that time distortion, particularly the perception of time moving slowly, can be a distinguishing feature in the early stages of anti-NMDA receptor encephalitis. This unique characteristic, especially when occurring independently of other symptoms, is rare as a primary and isolated symptom in other conditions, making it useful for differentiation from time distortion in other psychiatric disorders. Additionally, since some patients may not spontaneously report time distortion, actively assessing this symptom during early evaluation could help improve diagnostic accuracy.
Literature
1.
go back to reference Nissen MS, Ørvik MS, Nilsson AC, Ryding M, Lydolph M, Blaabjerg M. NMDA-receptor encephalitis in Denmark from 2009 to 2019: a national cohort study. J Neurol. 2022;269(3):1618–30.PubMedCrossRef Nissen MS, Ørvik MS, Nilsson AC, Ryding M, Lydolph M, Blaabjerg M. NMDA-receptor encephalitis in Denmark from 2009 to 2019: a national cohort study. J Neurol. 2022;269(3):1618–30.PubMedCrossRef
2.
go back to reference Ayubi E, Safiri S. Risk factors for mortality in patients with anti-NMDA receptor encephalitis; comment on data sparsity. Acta Neurol Scand. 2017;136(6):737.PubMedCrossRef Ayubi E, Safiri S. Risk factors for mortality in patients with anti-NMDA receptor encephalitis; comment on data sparsity. Acta Neurol Scand. 2017;136(6):737.PubMedCrossRef
3.
go back to reference Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12(2):157–65.PubMedPubMedCentralCrossRef Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12(2):157–65.PubMedPubMedCentralCrossRef
4.
go back to reference Giri YR, Parrill A, Damodar S, Fogel J, Ayed N, Syed M, et al. Anti-N-methyl-D-aspartate receptor encephalitis in adults: a systematic review and analysis. Neuropsychiatr. 2024;38(2):92–101.PubMedCrossRef Giri YR, Parrill A, Damodar S, Fogel J, Ayed N, Syed M, et al. Anti-N-methyl-D-aspartate receptor encephalitis in adults: a systematic review and analysis. Neuropsychiatr. 2024;38(2):92–101.PubMedCrossRef
5.
go back to reference Chapman MR, Vause HE. Anti-NMDA receptor encephalitis: diagnosis, psychiatric presentation, and treatment. Am J Psychiatry. 2011;168(3):245–51.PubMedCrossRef Chapman MR, Vause HE. Anti-NMDA receptor encephalitis: diagnosis, psychiatric presentation, and treatment. Am J Psychiatry. 2011;168(3):245–51.PubMedCrossRef
6.
go back to reference Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7(12):1091–8.PubMedPubMedCentralCrossRef Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7(12):1091–8.PubMedPubMedCentralCrossRef
8.
go back to reference Dalmau J, Armangué T, Planagumà J, Radosevic M, Mannara F, Leypoldt F, et al. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurol. 2019;18(11):1045–57.PubMedCrossRef Dalmau J, Armangué T, Planagumà J, Radosevic M, Mannara F, Leypoldt F, et al. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurol. 2019;18(11):1045–57.PubMedCrossRef
9.
go back to reference Al-Diwani A, Handel A, Townsend L, Pollak T, Leite MI, Harrison PJ, et al. The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data. Lancet Psychiatry. 2019;6(3):235–46.PubMedPubMedCentralCrossRef Al-Diwani A, Handel A, Townsend L, Pollak T, Leite MI, Harrison PJ, et al. The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data. Lancet Psychiatry. 2019;6(3):235–46.PubMedPubMedCentralCrossRef
10.
go back to reference Warren N, Siskind D, O’Gorman C. Refining the psychiatric syndrome of anti-N-methyl-d-aspartate receptor encephalitis. Acta Psychiatr Scand. 2018;138(5):401–8.PubMedCrossRef Warren N, Siskind D, O’Gorman C. Refining the psychiatric syndrome of anti-N-methyl-d-aspartate receptor encephalitis. Acta Psychiatr Scand. 2018;138(5):401–8.PubMedCrossRef
11.
go back to reference Gibson LL, Pollak TA, Blackman G, Thornton M, Moran N, David AS. The Psychiatric phenotype of Anti-NMDA receptor encephalitis. J Neuropsychiatry Clin Neurosci. 2019;31(1):70–9.PubMedCrossRef Gibson LL, Pollak TA, Blackman G, Thornton M, Moran N, David AS. The Psychiatric phenotype of Anti-NMDA receptor encephalitis. J Neuropsychiatry Clin Neurosci. 2019;31(1):70–9.PubMedCrossRef
12.
go back to reference Sarkis RA, Coffey MJ, Cooper JJ, Hassan I, Lennox B. Anti-N-Methyl-D-Aspartate receptor encephalitis: a review of Psychiatric Phenotypes and Management considerations: a report of the American Neuropsychiatric Association Committee on Research. J Neuropsychiatry Clin Neurosci. 2019;31(2):137–42.PubMedCrossRef Sarkis RA, Coffey MJ, Cooper JJ, Hassan I, Lennox B. Anti-N-Methyl-D-Aspartate receptor encephalitis: a review of Psychiatric Phenotypes and Management considerations: a report of the American Neuropsychiatric Association Committee on Research. J Neuropsychiatry Clin Neurosci. 2019;31(2):137–42.PubMedCrossRef
13.
go back to reference Giné Servén E, Boix Quintana E, Martínez Ramírez M, Guanyabens Buscà N, Muriana Batiste D, Guasp M, et al. Cycloid psychosis as a psychiatric expression of anti-NMDAR encephalitis. A systematic review of case reports accomplished with the authors’ cooperation. Brain Behav. 2021;11(2):e01980.PubMedCrossRef Giné Servén E, Boix Quintana E, Martínez Ramírez M, Guanyabens Buscà N, Muriana Batiste D, Guasp M, et al. Cycloid psychosis as a psychiatric expression of anti-NMDAR encephalitis. A systematic review of case reports accomplished with the authors’ cooperation. Brain Behav. 2021;11(2):e01980.PubMedCrossRef
14.
go back to reference Komagamine T, Kanbayashi T, Suzuki K, Hirata K, Nishino S. Atypical psychoses and anti-NMDA receptor encephalitis: a review of literature in the mid-twentieth century. Psychiatry Clin Neurosci. 2022;76(2):62–3.PubMedCrossRef Komagamine T, Kanbayashi T, Suzuki K, Hirata K, Nishino S. Atypical psychoses and anti-NMDA receptor encephalitis: a review of literature in the mid-twentieth century. Psychiatry Clin Neurosci. 2022;76(2):62–3.PubMedCrossRef
15.
go back to reference Subeh GK, Lajber M, Patel T, Mostafa JA. Anti-N-Methyl-D-Aspartate receptor encephalitis: a detailed review of the different Psychiatric presentations and red flags to look for in suspected cases. Cureus. 2021;13(5):e15188.PubMedPubMedCentral Subeh GK, Lajber M, Patel T, Mostafa JA. Anti-N-Methyl-D-Aspartate receptor encephalitis: a detailed review of the different Psychiatric presentations and red flags to look for in suspected cases. Cureus. 2021;13(5):e15188.PubMedPubMedCentral
16.
go back to reference Giri YR, Korie I, Hashmi S, Parrill A, Ayed N. Anti-NMDA receptor Encephalitis masquerades as psychosis: a Case Report. J Psychiatr Pract. 2022;28(1):72–7.PubMedCrossRef Giri YR, Korie I, Hashmi S, Parrill A, Ayed N. Anti-NMDA receptor Encephalitis masquerades as psychosis: a Case Report. J Psychiatr Pract. 2022;28(1):72–7.PubMedCrossRef
17.
go back to reference Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15(4):391–404.PubMedPubMedCentralCrossRef Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15(4):391–404.PubMedPubMedCentralCrossRef
18.
go back to reference Finke C, Kopp UA, Prüss H, Dalmau J, Wandinger KP, Ploner CJ. Cognitive deficits following anti-NMDA receptor encephalitis. J Neurol Neurosurg Psychiatry. 2012;83(2):195–8.PubMedCrossRef Finke C, Kopp UA, Prüss H, Dalmau J, Wandinger KP, Ploner CJ. Cognitive deficits following anti-NMDA receptor encephalitis. J Neurol Neurosurg Psychiatry. 2012;83(2):195–8.PubMedCrossRef
19.
go back to reference Byrne S, Walsh C, Hacohen Y, Muscal E, Jankovic J, Stocco A, et al. Earlier treatment of NMDAR antibody encephalitis in children results in a better outcome. Neurol Neuroimmunol Neuroinflamm. 2015;2(4):e130.PubMedPubMedCentralCrossRef Byrne S, Walsh C, Hacohen Y, Muscal E, Jankovic J, Stocco A, et al. Earlier treatment of NMDAR antibody encephalitis in children results in a better outcome. Neurol Neuroimmunol Neuroinflamm. 2015;2(4):e130.PubMedPubMedCentralCrossRef
20.
go back to reference Finke C, Kopp UA, Pajkert A, Behrens JR, Leypoldt F, Wuerfel JT, et al. Structural hippocampal damage following Anti-N-Methyl-D-Aspartate receptor encephalitis. Biol Psychiatry. 2016;79(9):727–34.PubMedCrossRef Finke C, Kopp UA, Pajkert A, Behrens JR, Leypoldt F, Wuerfel JT, et al. Structural hippocampal damage following Anti-N-Methyl-D-Aspartate receptor encephalitis. Biol Psychiatry. 2016;79(9):727–34.PubMedCrossRef
21.
go back to reference Lee WJ, Lee ST, Moon J, Sunwoo JS, Byun JI, Lim JA, et al. Tocilizumab in Autoimmune Encephalitis Refractory to Rituximab: an institutional cohort study. Neurotherapeutics. 2016;13(4):824–32.PubMedPubMedCentralCrossRef Lee WJ, Lee ST, Moon J, Sunwoo JS, Byun JI, Lim JA, et al. Tocilizumab in Autoimmune Encephalitis Refractory to Rituximab: an institutional cohort study. Neurotherapeutics. 2016;13(4):824–32.PubMedPubMedCentralCrossRef
22.
go back to reference Funayama M, Koreki A, Takata T, Kurose S, Hisamatsu T, Ono A, et al. Differentiating autoimmune encephalitis from schizophrenia spectrum disorders among patients with first-episode psychosis. J Psychiatr Res. 2022;151:419–26.PubMedCrossRef Funayama M, Koreki A, Takata T, Kurose S, Hisamatsu T, Ono A, et al. Differentiating autoimmune encephalitis from schizophrenia spectrum disorders among patients with first-episode psychosis. J Psychiatr Res. 2022;151:419–26.PubMedCrossRef
23.
go back to reference McCarron MM, Schulze BW, Thompson GA, Conder MC, Goetz WA. Acute phencyclidine intoxication: incidence of clinical findings in 1,000 cases. Ann Emerg Med. 1981;10(5):237–42.PubMedCrossRef McCarron MM, Schulze BW, Thompson GA, Conder MC, Goetz WA. Acute phencyclidine intoxication: incidence of clinical findings in 1,000 cases. Ann Emerg Med. 1981;10(5):237–42.PubMedCrossRef
24.
go back to reference Pikwer A. Depersonalization disorder may be related to glutamate receptor activation imbalance. Med Hypotheses. 2011;77(4):593–4.PubMedCrossRef Pikwer A. Depersonalization disorder may be related to glutamate receptor activation imbalance. Med Hypotheses. 2011;77(4):593–4.PubMedCrossRef
25.
go back to reference Mechri A, Saoud M, Khiari G, d’Amato T, Dalery J, Gaha L. Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine. Encephale. 2001;27(1):53–9.PubMed Mechri A, Saoud M, Khiari G, d’Amato T, Dalery J, Gaha L. Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine. Encephale. 2001;27(1):53–9.PubMed
26.
go back to reference Pomarol-Clotet E, Honey GD, Murray GK, Corlett PR, Absalom AR, Lee M, et al. Psychological effects of ketamine in healthy volunteers. Phenomenological study. Br J Psychiatry. 2006;189:173–9.PubMedCrossRef Pomarol-Clotet E, Honey GD, Murray GK, Corlett PR, Absalom AR, Lee M, et al. Psychological effects of ketamine in healthy volunteers. Phenomenological study. Br J Psychiatry. 2006;189:173–9.PubMedCrossRef
27.
go back to reference Varley J, Vincent A, Irani SR. Clinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directions. J Neurol. 2015;262(4):1081–95.PubMedCrossRef Varley J, Vincent A, Irani SR. Clinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directions. J Neurol. 2015;262(4):1081–95.PubMedCrossRef
28.
29.
go back to reference Funayama M, Mizushima J, Takata T, Koreki A, Mimura M. Altered perception might be a symptom of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis. Neurocase. 2018;24(5–6):255–8.PubMedCrossRef Funayama M, Mizushima J, Takata T, Koreki A, Mimura M. Altered perception might be a symptom of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis. Neurocase. 2018;24(5–6):255–8.PubMedCrossRef
30.
go back to reference Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974;2(7872):81–4.PubMedCrossRef Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974;2(7872):81–4.PubMedCrossRef
31.
go back to reference Ideno Y, Takayama M, Hayashi K, Takagi H, Sugai Y. Evaluation of a Japanese version of the Mini-mental State examination in elderly persons. Geriatr Gerontol Int. 2012;12(2):310–6.PubMedCrossRef Ideno Y, Takayama M, Hayashi K, Takagi H, Sugai Y. Evaluation of a Japanese version of the Mini-mental State examination in elderly persons. Geriatr Gerontol Int. 2012;12(2):310–6.PubMedCrossRef
32.
go back to reference Quinn TJ, Dawson J, Walters MR, Lees KR. Reliability of the modified Rankin Scale: a systematic review. Stroke. 2009;40(10):3393–5.PubMedCrossRef Quinn TJ, Dawson J, Walters MR, Lees KR. Reliability of the modified Rankin Scale: a systematic review. Stroke. 2009;40(10):3393–5.PubMedCrossRef
33.
go back to reference Shinohara Y, Minematsu K, Amano T, Ohashi Y. Modified Rankin scale with expanded guidance scheme and interview questionnaire: interrater agreement and reproducibility of assessment. Cerebrovasc Dis. 2006;21(4):271–8.PubMedCrossRef Shinohara Y, Minematsu K, Amano T, Ohashi Y. Modified Rankin scale with expanded guidance scheme and interview questionnaire: interrater agreement and reproducibility of assessment. Cerebrovasc Dis. 2006;21(4):271–8.PubMedCrossRef
34.
go back to reference Allman MJ, Meck WH. Pathophysiological distortions in time perception and timed performance. Brain. 2012;135(Pt 3):656–77.PubMedCrossRef Allman MJ, Meck WH. Pathophysiological distortions in time perception and timed performance. Brain. 2012;135(Pt 3):656–77.PubMedCrossRef
35.
go back to reference Teixeira S, Machado S, Paes F, Velasques B, Silva JG, Sanfim AL, et al. Time perception distortion in neuropsychiatric and neurological disorders. CNS Neurol Disord Drug Targets. 2013;12(5):567–82.PubMedCrossRef Teixeira S, Machado S, Paes F, Velasques B, Silva JG, Sanfim AL, et al. Time perception distortion in neuropsychiatric and neurological disorders. CNS Neurol Disord Drug Targets. 2013;12(5):567–82.PubMedCrossRef
36.
go back to reference Stanghellini G, Ballerini M, Presenza S, Mancini M, Raballo A, Blasi S, et al. Psychopathology of Lived Time: abnormal time experience in persons with Schizophrenia. Schizophr Bull. 2016;42(1):45–55.PubMed Stanghellini G, Ballerini M, Presenza S, Mancini M, Raballo A, Blasi S, et al. Psychopathology of Lived Time: abnormal time experience in persons with Schizophrenia. Schizophr Bull. 2016;42(1):45–55.PubMed
37.
go back to reference Fouks L, Guibert S, Montot M. Minkowski’s concept of lived time. Ann Med Psychol (Paris). 1989;147(8):801–9.PubMed Fouks L, Guibert S, Montot M. Minkowski’s concept of lived time. Ann Med Psychol (Paris). 1989;147(8):801–9.PubMed
38.
go back to reference Martin B, Franck N, Cermolacce M, Coull JT, Giersch A. Minimal self and timing disorders in Schizophrenia: a Case Report. Front Hum Neurosci. 2018;12:132.PubMedPubMedCentralCrossRef Martin B, Franck N, Cermolacce M, Coull JT, Giersch A. Minimal self and timing disorders in Schizophrenia: a Case Report. Front Hum Neurosci. 2018;12:132.PubMedPubMedCentralCrossRef
39.
go back to reference Cutting J, Silzer H. Psychopathology of time in brain disease and schizophrenia. Behav Neurol. 1990;3(4):197–215.PubMedCrossRef Cutting J, Silzer H. Psychopathology of time in brain disease and schizophrenia. Behav Neurol. 1990;3(4):197–215.PubMedCrossRef
40.
go back to reference Blom JD, Nanuashvili N, Waters F. Time distortions: a systematic review of cases characteristic of Alice in Wonderland Syndrome. Front Psychiatry. 2021;12:668633.PubMedPubMedCentralCrossRef Blom JD, Nanuashvili N, Waters F. Time distortions: a systematic review of cases characteristic of Alice in Wonderland Syndrome. Front Psychiatry. 2021;12:668633.PubMedPubMedCentralCrossRef
42.
go back to reference Mastria G, Mancini V, Viganò A, Di Piero V. Alice in Wonderland Syndrome: a clinical and pathophysiological review. Biomed Res Int. 2016;2016:8243145.PubMedPubMedCentralCrossRef Mastria G, Mancini V, Viganò A, Di Piero V. Alice in Wonderland Syndrome: a clinical and pathophysiological review. Biomed Res Int. 2016;2016:8243145.PubMedPubMedCentralCrossRef
43.
go back to reference Giannotti AM. Síndrome De Alicia en El País De Las Maravillas E infección por virus de Epstein Barr. Arch. Argent. Pediatr; 2003. pp. 41–3. Giannotti AM. Síndrome De Alicia en El País De Las Maravillas E infección por virus de Epstein Barr. Arch. Argent. Pediatr; 2003. pp. 41–3.
44.
go back to reference Pérez Méndez C, Martín Mardomingo M, Otero Martínez B, Lagunilla Herrero L, Fernández Zurita C. [Alice in Wonderland syndrome due to Epstein-Barr virus infection]. Esp Pediatr. 2001;54(6):601–2.CrossRef Pérez Méndez C, Martín Mardomingo M, Otero Martínez B, Lagunilla Herrero L, Fernández Zurita C. [Alice in Wonderland syndrome due to Epstein-Barr virus infection]. Esp Pediatr. 2001;54(6):601–2.CrossRef
45.
go back to reference Augarten A, Aderka D. Alice in Wonderland syndrome in H1N1 influenza: case report. Pediatr Emerg Care. 2011;27(2):120.PubMedCrossRef Augarten A, Aderka D. Alice in Wonderland syndrome in H1N1 influenza: case report. Pediatr Emerg Care. 2011;27(2):120.PubMedCrossRef
46.
go back to reference Hansen N. NMDAR autoantibodies in psychiatric disease - an immunopsychiatric continuum and potential predisposition for disease pathogenesis. J Transl Autoimmun. 2022;5:100165.PubMedPubMedCentralCrossRef Hansen N. NMDAR autoantibodies in psychiatric disease - an immunopsychiatric continuum and potential predisposition for disease pathogenesis. J Transl Autoimmun. 2022;5:100165.PubMedPubMedCentralCrossRef
47.
go back to reference Hansen N, Luedecke D, Maier HB, Neyazi A, Fitzner D, Wiltfang J, Malchow B. NMDAR1 autoantibodies as potential biomarkers for schizophrenia phenotyping. Lancet Psychiatry. 2024;11(10):780–1.PubMedCrossRef Hansen N, Luedecke D, Maier HB, Neyazi A, Fitzner D, Wiltfang J, Malchow B. NMDAR1 autoantibodies as potential biomarkers for schizophrenia phenotyping. Lancet Psychiatry. 2024;11(10):780–1.PubMedCrossRef
Metadata
Title
Time moving 100-fold slower: time distortion as a diagnostic clue in anti-NMDA receptor encephalitis
Authors
Risa Hirata
Hisashi Wada
Kazunori Yamamoto
Yuji Sogi
Hiroto Muzuta
Yu Isaka
Michitaka Funayama
Publication date
24-02-2025
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2025
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-025-04078-8

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now
Video

Advances in Alzheimer's

Alzheimer's research and care is changing rapidly. Keep up with the latest developments from key international conferences, together with expert insights on how to integrate these advances into practice.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Healthcare IME
Learn more